Citations with the tag: RECTUM -- Cancer -- Treatment

Results 1 - 50

     // Canadian Journal of Surgery; Aug2006 Supplement, Vol. 49, p7 

    An abstract of the article "Neoadjuvant Chemoradiation and Anastomotic Leak After Total Mesorectal Excision for Rectal Cancer," by Y. AlSuhaibani, I. Pinsk, F. Haggar, M. Friedlich, H. Stern and R. P. Boushey is presented.

  • A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation...
    Gelber, Richard D.; Goldhirsch, Aron // JNCI: Journal of the National Cancer Institute; 08/07/96, Vol. 88 Issue 15, p1039 

    Focuses on the improvement of survival rates for rectal cancer patients receiving adjuvant radiation therapy and chemotherapy following surgery. Assessment of toxic effects of cancer treatment; Analysis standards used to determine treatment success.

  • Preoperative Rectal Cancer Management: Wide International Practice Makes Outcome Comparison Challenging: Reply.
    Augestad, Knut M.; Lindsetmo, Rolv-Ole; Stulberg, Jonah; Reynolds, Harry; Champagne, Brad; Leblanc, Fabien; Heriot, Alexander G.; Senagore, Anthony; Delaney, Conor // World Journal of Surgery; Jun2011, Vol. 35 Issue 6, p1418 

    A response by Knut M. Augestad and colleagues to a letter to the editor on their article on a survey on neoadjuvant treatment of rectal cancer management in the 2010 issue is presented.

  • Preoperative Chemoradiation and Coloanal J Pouch Reconstruction for Low Rectal Cancer.
    Chaudhry, Vivek; Nittala, Murali; Prasad, Madhava L. // American Surgeon; Apr2000, Vol. 66 Issue 4, p387 

    Our objective was to determine clinical outcomes of treatment of low rectal adenocarcinoma with neoadjuvant chemoradiation, rectal excision, and coloanal J pouch reconstruction. A retrospective review of 69 patients with stage B2 or higher lesions was performed. Preoperative chemoradiation was...

  • Calcium supplementation and rectal mucosal proliferation: A randomized controlled trial.
    Baron, John A.; Tosteson, Tor D. // JNCI: Journal of the National Cancer Institute; 9/6/95, Vol. 87 Issue 17, p1303 

    Examines the effect of calcium supplementation on rectal mucosal proliferation in humans. Absence of effect of calcium supplementation on rectal mucosal proliferation; Insufficiency of evidence for the anticarcinogenic effect of calcium.

  • Colorectal carcinoma in patients 30 years of age and younger.
    McGahren III, Eugene D.; Mills, Stacey E. // American Surgeon; Jan1995, Vol. 61 Issue 1, p78 

    Studies the treatment of colorectal cancer in patients aged 30 years or younger at the University of Virginia Health Sciences Center. Physical findings; Onset of symptoms; Precancerous conditions; Surgical interventions.

  • Biological Effects of Preoperative Radiotherapy on Metastatic Lymph Nodes from Rectal Cancer.
    Ibi, Italo; Saito, Yukio; Agnifili, Alessio; De Bernardinis, Giancarlo; Citone, Girgio; Muto, Tetsuichiro // American Surgeon; May1999, Vol. 65 Issue 5, p427 

    Provides information on a study regarding the biological effect of adjuvant therapy on metastatic lymph nodes from rectal cancer. Information on proliferating cell nuclear antigen (PCNA) immunostaining; Evaluation of the PCNA staining; Statistical analysis of the clinical trial conducted.

  • Advanced rectal cancer.
    Williams, J. Alexander // BMJ: British Medical Journal (International Edition); 2/3/90, Vol. 300 Issue 6720, p276 

    Focuses on the conservative and palliative management of advanced rectal cancer. Use of local resection by the transanal or transphincteric route; Clinical trials on chemotherapy in rectal cancer; Efficacy of diathermy resection in a fluid medium.

  • Long-term survival after "liver first" approach for locally advanced rectal cancer and synchronous liver metastases.
    Radunz, Sonia; Heuer, Matthias; Trarbach, Tanja; Mathe, Zoltan; Baba, Hideo A.; Paul, Andreas; Sotiropoulos, Georgios C. // International Journal of Colorectal Disease; Sep2011, Vol. 26 Issue 9, p1219 

    A letter to the editor is presented in response to an article concerning the treatment of advanced rectal cancer and synchronous colorectal liver metastases.

  • Decreasing Anastomotic Leakage Rate Following Preoperative Radiotherapy and Low Anterior Resection for Rectal Cancer: Reply.
    Jin Gu; Lin Wang // World Journal of Surgery; Jan2011, Vol. 35 Issue 1, p241 

    A response by Jin Gu and Lin Wang to a letter to the editor about their article "Risk factors for symptomatic anastomotic leakage after low anterior resection for rectal cancer with 30 Gy/ 10 f/2 w preoperative radiotherapy," in a previous issue is presented.

  • Predicting and Preventing Anastomotic Leakage after Low Anterior Resection for Rectal Cancer.
    Hottenrott, Christof // World Journal of Surgery; Jan2011, Vol. 35 Issue 1, p239 

    A letter to the editor in reponse to the article "Risk factors for symptomatic anastomotic leakage after low anterior resection for rectal cancer with 30 Gy/ 10 f/2 w preoperative radiotherapy," by Lin Wang and Jin Gu in a previous issue is presented.

  • Differences found in rectal cancer treatment between European countries.
    Hottenrott, Christof // Hem/Onc Today; 10/25/2011, Vol. 12 Issue 20, p38 

    The article discusses the findings of a study by Colette van den Broek and colleagues which showed differences in the use of chemotherapy and radiotherapy for rectal cancer between European countries.

  • Commentary: Rectal Cancer--An Evolution of Treatment.
    Czito, Brian G.; Willett, Christopher G. // Oncologist; Nov2007, Vol. 12 Issue 11, p1319 

    The article focuses on the evolution of treatment of rectal cancer. It states that neoadjuvant chemoradiotherapy with total mesorectal excision has become a standard treatment for the locally advanced disease in the U.S. and Europe. It mentions that newer generation cytotoxic chemotherapeutics...

  • Optimising Treatment for Resectable Rectal Cancer: Is Preoperative Therapy Beneficial?
    Ngan, S.Y.K. // Drugs & Aging; 2001, Vol. 18 Issue 2, p79 

    Preoperative radiotherapy is becoming the standard of care for resectable locally advanced adenocarcinoma of the rectum. Its practice is no longer limited to a few specialised cancer centres. Adjuvant preoperative radiotherapy can reduce the risk of local recurrence by 50% compared with surgery...

  • Fluorouracil.
    Ngan, S.Y.K. // Reactions Weekly; 1/29/2011, Issue 1336, p23 

    The article describes the case of a 76-year-old male patient who developed coronary spasm during chemotherapy combined with fluorouracil and capecitabine to treat adenocarcinoma of the rectum.

  • Therapy changes "sharply" increase survival in rectal cancer.
    Ngan, S.Y.K. // PharmacoEconomics & Outcomes News; 3/20/2010, Issue 599, p8 

    The article discusses research by M. A. Elferink et al, published in the February 19, 2010 issue of the "European Journal of Cancer," which found that new forms of therapy, such as preoperative radiotherapy and chemotherapy, have greatly benefited those suffering from rectal cancer.

  • No long-term QOL benefit for CRT.
    Ngan, S.Y.K. // PharmacoEconomics & Outcomes News; 9/17/2011, Issue 637, p10 

    The article reports on research from Norway and Sweden which revealed that preoperative chemoradiotherapy (CRT) does not offer better long-term health-related quality of life (QOL) benefit in patients with primarily non-resectable rectal cancer, in comparison to radiotherapy alone.

  • Reply to: doi:10.1007/s0046-4-010-1485-0: Re: Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer: 'narrow pelvis' is not a contraindication (Surg Endosc 2011 Jan;25:1907-1912).
    Ogiso, Satoshi; Yamaguchi, Takashi; Sakai, Yoshiharu // Surgical Endoscopy; Oct2012, Vol. 26 Issue 10, p2993 

    A response from the authors of the article "Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer: "narrow pelvis" is not a contraindication" in the 2011 issue is presented.

  • Ephedrine.
    Ogiso, Satoshi; Yamaguchi, Takashi; Sakai, Yoshiharu // Reactions Weekly; 5/18/2013, Issue 1453, p20 

    The article presents a case study of a 63-year-old man with reparalysis which developed after receiving ephedrine for anterior resection for rectal cancer, while he is recovering from neuromuscular blockade.

  • Radiation therapy plus surgery extended OS in metastatic rectal cancer.
    Ogiso, Satoshi; Yamaguchi, Takashi; Sakai, Yoshiharu // Hem/Onc Today; 1/10/2014, Vol. 15 Issue 1, p8 

    The article discusses the study that found longer survival in patients with primary rectal or rectosigmoid tumors, who were treated with pelvic radiation therapy and surgery compared to those treated with surgery alone, a treatment commonly used in patients with rectosigmoid tumors.

  • Does a learning curve exist in endorectal two-dimensional ultrasound accuracy?
    Jadav, A.; Mumbi, C.; Brown, S. // Techniques in Coloproctology; Feb2013, Vol. 17 Issue 1, p125 

    A letter to the editor is presented in response to the article "Does a learning curve exist in endorectal two-dimensional ultrasound accuracy?," by O. J. Morris, B. Draganic and S. Smith in the 2011 issue.

  • Current evidence-based opinions in the management of adenocarcionoma of the rectum.
    Huerta, Sergio; Murray, Bryce; Olson, Craig; Patel, Prapti; Anthony, Thomas // Indian Journal of Surgery; Dec2009, Vol. 71 Issue 6, p356 

    The management of rectal cancer has drastically evolved over the past two decades as a result of implementation of circular stapling devices and the introduction of neoadjuvant chemoradiation. In spite of current aggressive multimodality treatments, the recurrence rate remains unacceptably high...

  • Local recurrence after rectal cancer treatment in Manitoba.
    Latosinsky, Steven; Turner, Donna // Canadian Journal of Surgery; Feb2009, Vol. 52 Issue 1, p45 

    Background: By optimizing surgical and/or radiotherapy treatment, local recurrence rates of resectable rectal cancers have been reported to be less than 10% in both clinical trials and in some population-based studies. We examined patterns of care and local recurrence rates for rectal cancers in...

  • Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer.
    Sun, D.-S.; Zhang, J.-D.; Li, L.; Y. Dai; Yu, J.-M.; Shao, Z.-Y. // British Journal of Radiology; Mar2012, Vol. 85 Issue 1011, p259 

    Objectives: To evaluate the efficacy and treatment-related toxicity of accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer (LRIRC). Methods: 72 patients with LRIRC who underwent the...

  • Evaluation of the learning curve in laparoscopic low anterior resection for rectal cancer.
    Kayano, Hajime; Okuda, Junji; Tanaka, Keitaro; Kondo, Keisaku; Tanigawa, Nobuhiko // Surgical Endoscopy; Sep2011, Vol. 25 Issue 9, p2972 

    Background: Laparoscopic low anterior resection for rectal cancer is considered to be more technically demanding than laparoscopic colectomy. This study aimed to analyze the learning curve for laparoscopic low anterior resection and to identify the factors that influence this learning curve....

  • Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Terzi, Cem; Canda, Aras Emure; Sagol, Ozgul; Atila, Koray; Sonmez, Devrim; Fuzun, Mehmet; Gorken, Ilknur B.; Oztop, Ilhan; Obuz, Funda // International Journal of Colorectal Disease; Jan2008, Vol. 23 Issue 1, p37 

    The ability to predict response to chemoradiotherapy before the treatment may allow protecting poorly responding patients from the side effects of neoadjuvant treatment. Several molecular markers have been proposed to radio and chemosensitivity of rectal cancer. In this study, from...

  • Lokale Diagnostik beim Rektumkarzinom.
    Ptok, H.; Gastinger, I.; Lippert, H. // Der Chirurg; May2012, Vol. 83 Issue 5, p448 

    Accurate pretherapeutic staging of rectal cancer is crucial for further therapeutic management and important for prognosis. The most accurate diagnostic tools in the assessment of T and N categories of rectal cancer are endorectal ultrasound (EUS) and magnetic resonance imaging (MRI)....

  • Pathologisches Staging und Response-Evaluation beim Rektumkarzinom.
    Wittekind, C.; Oberschmid, B // Der Chirurg; May2012, Vol. 83 Issue 5, p423 

    The application of so-called neoadjuvant therapy may induce changes in tumor tissues that have to be determined concerning the degree of severity (regression grading) and which also influence pathological staging. The extent of morphological changes (response) to be evaluated ranges from...

  • Valor pronóstico de la respuesta patológica a la radioquimioterapia preoperatoria en el cáncer de recto bajo localmente avanzado.
    BANNURA C., GUILLERMO; VARGAS N., CLAUDIO; BARRERA E., ALEJANDRO; MELO L., CARLOS; ILLANES F., FELIPE // Revista Chilena de Cirugia; Jun2013, Vol. 65 Issue 3, p236 

    Background: Preoperative chemo radiotherapy improves the prognosis of locally advanced low rectal cancer and induces a pathological response in the tumor, which may have prognostic value. Aim: To assess the results of rectal cancer treatment according to the degree of pathological response of...

  • Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution.
    Dionisi, Francesco; Musio, Daniela; Raffetto, Nicola; Codacci-Pisanelli, Giovanni; Iannacone, Eva; Caiazzo, Rossella; Banelli, Enzo // International Journal of Colorectal Disease; Feb2011, Vol. 26 Issue 2, p153 

    Purpose: The aim of our study was to evaluate the feasibility and the effectiveness of an intensified neoadjuvant protocol with the addition of weekly oxaliplatin in the preoperative strategy of rectal cancer treatment. Patients and methods: Patients with locally advanced rectal cancer received...

  • A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer.
    Chen, Chin-Fan; Huang, Ming-Yii; Huang, Chih-Jen; Wu, Chan-Han; Yeh, Yung-Sung; Tsai, Hsiang-Lin; Ma, Cheng-Jen; Lu, Chien-Yu; Chang, Shun-Jen; Chen, Ming-Jenn; Wang, Jaw-Yuan // International Journal of Colorectal Disease; Jun2012, Vol. 27 Issue 6, p727 

    Background and objectives: This study is to evaluate the safety and efficacy of preoperative radiotherapy (RT) combined with bolus infusional 5-fluorouracil (5-FU) or oral capecitabine in patients with locally advanced rectal cancer (LARC). Materials and methods: Seventy-four patients were...

  • Irinotecan.
    Chen, Chin-Fan; Huang, Ming-Yii; Huang, Chih-Jen; Wu, Chan-Han; Yeh, Yung-Sung; Tsai, Hsiang-Lin; Ma, Cheng-Jen; Lu, Chien-Yu; Chang, Shun-Jen; Chen, Ming-Jenn; Wang, Jaw-Yuan // Reactions Weekly; 10/8/2011, Issue 1372, p21 

    The article describes the cases of two patients who developed febrile neutropenia following treatment with irinotecan for metastatic rectal cancer or sigmoid colon cancer.

  • UC Irvine Health Leads U.S. Study of Robotic Surgery for Cancer.
    Pigazzi, Alessio // Orange County Business Journal; 7/22/2013, Vol. 36 Issue 29, pB-42 

    The article focuses on Alessio Pigazzi, surgeon and chief of the Division of Colon and Rectal Cancer Surgery at University of California (UC) Irvine Health in Irvine, California who leads the U.S. for an international study of using robotic surgery in the treatment of rectal cancer.

  • Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish rectal cancer registry 1995-2004.
    Jung, Bärbel; Påhlman, Lars; Johansson, Robert; Nilsson, Erik // BMC Cancer; 2009, Vol. 9, Special section p1 

    Background: Limited information is available regarding the effect of age on choice of surgical and oncological treatment for rectal cancer. The objective of this study was to assess the influence of age on treatment and outcome of rectal cancer. Methods: We utilized data in the Swedish Rectal...

  • The Difficulty with Localization of Rectal Cancer after Neoadjuvant Chemoradiation Therapy.
    TORRES, MARLA L.; McCAFFERTY, MICHAEL H.; JORDEN, JEFFREY // American Surgeon; Sep2010, Vol. 76 Issue 9, p974 

    Neoadjuvant chemoradiation therapy (NCRT) has become the standard treatment for locally advanced rectal cancer. Subsequent downstaging can make identification of the primary tumor challenging. Complete pathologic response rates of 8 per cent to 27 per cent are seen with current NCRT regimen. Two...

  • Multidisciplinary Discussion and Management of Rectal Cancer: A Population-based Study.
    Swellengrebel, H. A. M.; Peters, E. G.; Cats, A.; Visser, O.; Blaauwgeers, H. G. T.; Verwaal, V. J.; van Velthuysen, M. L.; Cense, H. A.; Bruin, S. C.; Marijnen, C. A. M. // World Journal of Surgery; Sep2011, Vol. 35 Issue 9, p2125 

    Background: The purpose of the present study was to evaluate the value of discussing rectal cancer patients in a multidisciplinary team (MDT). Methods: All treated rectal cancer patients (>T1M0) diagnosed in 2006-2008 were included. According to the national guidelines, neoadjuvant...

  • The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Joo Ho Lee; Eui Kyu Chie; Kyubo Kim; Seung-Yong Jeong; Kyu Joo Park; Jae-Gahb Park; Gyeong Hoon Kang; Sae-Won Han; Do-Youn Oh; Tae-You Kim; Yung-Jue Bang; Ha, Sung W. // BMC Cancer; 2013, Vol. 13 Issue 1, p1 

    Background Circumferential resection margin (CRM) and distal resection margin (DRM) have different impact on clinical outcomes after preoperative chemoradiotherapy (CRT) followed by surgery. Effect and adequate length of resection margin as well as impact of treatment response after preoperative...

  • Long-term Outcome of Local Excision after Complete Pathological Response to Neoadjuvant Chemoradiation Therapy for Rectal Cancer.
    Issa, Nidal; Murninkas, Alejandro; Powsner, Eldad; Dreznick, Zeev // World Journal of Surgery;  

    Background: Neoadjuvant chemoradiotion therapy (CRT) for advanced rectal cancer has improved local disease. Complete rectal wall tumor regression may be associated with the absence of viable cancer cells in the mesorectum, and thus local excision (LE) of such lesions as an alternative to radical...


    The aim of this study was to compare the short-term outcome of laparoscopic surgery and open surgery in the treatment of rectal cancer. Materials and methods. This prospective clinical study, carried out between 2008-2011, included 260 patients with rectal cancer, of which 60 were treated by...

  • Capecitabine.

    The article presents a case study of a 70-year-old man diagnosed with various toxicities developed while receiving capecitabine for his rectal cancer.

  • A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillance.
    Cafferty, Fay H.; Sasieni, Peter D.; Duffy, Stephen W. // Statistical Methods in Medical Research; Apr2009, Vol. 18 Issue 2, p163 

    There is evidence that the removal of adenomas, by endoscopy, from the large bowel can prevent the occurrence of colorectal cancer (CRC). However, the reduction in cancer incidence due to endoscopic surveillance is difficult to estimate. Studies of cohorts of adenoma patients typically rely on...

  • Effects of Topical Tumoricidal Agents on Port-Site Recurrence of Colon Cancer: An Experimental Study in Rats.
    Hoffstetter, Wayne; Ortega, Adrian; Chiang, Mimi; Paik, Peter; Beart, Robert W. // Journal of Laparoendoscopic & Advanced Surgical Techniques; Feb2001, Vol. 11 Issue 1, p9 

    Background: Reports of metastatic spread of colon and rectal cancer to port sites after laparoscopic resection of potentially curable lesions has raised doubt regarding the efficacy and safety of laparoscopic technology in cancer surgery. Experimental study in animals has led us to believe that...

  • Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey.
    Habr-Gama, A.; Perez, R. O.; S�o Juli�o, G. P.; Proscurshim, I.; Nahas, S. C.; Gama-Rodrigues, J. // Techniques in Coloproctology; Mar2011, Vol. 15 Issue 1, p45 

    Background: Management of rectal cancer has become increasingly complex and a multidisciplinary approach is considered of key importance for improving outcomes. A national survey among specialists involved in this multidisciplinary setting was performed. Methods: A web-based survey containing 11...

  • The Use of Pelvic Radiation in Stage II Rectal Cancer: A Population-Based Analysis.
    KUO, ISABELLA; WONG, JAN H.; ROY-CHOWDHURY, SHARMILA; LUM, SHARON S.; MORGAN, JOHN W.; KAZANJIAN, KEVORK // American Surgeon; Oct2010, Vol. 76 Issue 10, p1092 

    National Institutes of Health (NIH) guidelines recommend the use of pelvic radiation in T3N0 rectal cancer. We sought to determine the rate of compliance with NIH radiation guidelines for patients with T3N0 rectal cancer. We performed a retrospective cohort study of T3N0 rectal cancer diagnosed...

  • The Impact of Multidisciplinary Therapy in Node-Positive Rectal Cancer.
    ROOS, MATTHEW; WONG, JAN H.; ROY-CHOWDHURY, SHARMILA; LUM, SHARON S.; MORGAN, JOHN W.; KAZANJIAN, KEVORK // American Surgeon; Oct2010, Vol. 76 Issue 10, p1163 

    Multidisciplinary therapy (MDT) of node-positive rectal cancer is considered optimal. We performed a retrospective cohort study of node positive rectal cancer patients diagnosed between January 1, 1994 and December 31, 2003 in Region 5 of the California Cancer Registry to determine the impact of...

  • Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study.
    Klautke, G.; K�chenmeister, U.; Foitzik, T.; Ludwig, K.; Prall, F.; Klar, E.; Fietkau, R. // British Journal of Cancer; 4/10/2006, Vol. 94 Issue 7, p976 

    The aim of this study was to investigate the efficacy and safety of chemoradiation using capecitabine and irinotecan as neoadjuvant therapy for patients with rectal cancer. Conventional radiation was given at daily fractions of 1.8 Gy on 5 days a week for a total dose of 55.8 (50.4+5.4) Gy....

    Lozneanu, Lili-Gabriela // Jurnalul de Chirurgie; 2011, Vol. 7 Issue 4, p511 

    Despite advances in screening, rectal cancer remain widely prevalent. The location of the rectum within the pelvis presents challenges with regard to evaluation, staging and resection of rectal cancer. Surgery remain the mainstay of treatment, it is standardized (Total Mesorectal Excision -...

  • Prognostic significance of adverse events associated with preoperative radiotherapy for rectal cancer.
    Ishihara, Soichiro; Watanabe, Toshiaki; Akahane, Takuya; Shimada, Ryu; Horiuchi, Atsushi; Shibuya, Hajima; Hayama, Tamuro; Yamada, Hideki; Nozawa, Keijiro; Igaki, Hiroshi; Matsuda, Keiji // International Journal of Colorectal Disease; Jul2011, Vol. 26 Issue 7, p911 

    Purpose: Adverse events may occur in patients receiving preoperative radiotherapy (PRT) for rectal cancers. The aim of this study is to clarify the clinical and pathological features of the patients with PRT-related adverse events, and the significance of the adverse events on the clinical...

  • Chemo Plus Radiation Before Surgery Boosts Tumor Response.
    Ishihara, Soichiro; Watanabe, Toshiaki; Akahane, Takuya; Shimada, Ryu; Horiuchi, Atsushi; Shibuya, Hajima; Hayama, Tamuro; Yamada, Hideki; Nozawa, Keijiro; Igaki, Hiroshi; Matsuda, Keiji // Radiology Today; Dec2011, Vol. 12 Issue 12, p31 

    The article focuses on a research which suggests that rectal cancer patient who utilize a new combination of the chemotherapy called capecitabine together with five weeks of radiation before surgery have an 88% chance of surviving the cancer. Radiation Oncologist Jean Pierre Gerard, highlights...

  • Quality Assurance Through Outcome Registration in Colorectal Cancer: An ECCO Initiative for Europe.
    van Gijn, Willem; van de Velde, Cornelis J. H. // European Journal of Clinical & Medical Oncology; 2011, Vol. 3 Issue 3, p1 

    In recent years there have been significant improvements in the outcome of rectal cancer treatment. Both new surgical techniques as well as effective neoadjuvant treatment regimens have contributed to these improvements. It is key to spread these advances toward every rectal cancer patient and...

Next 50 Results

Other Topics